EUVIMEDEUVIMED entdecken
Crossref

METTL3 promotes choriocarcinoma progression by activating the miR‐935/GJA1 pathway in an m6A‐dependent manner

Wenzhi Wang iD, Jianyong Shi, Lei Zheng

American Journal of Reproductive Immunology · 2023

DOI: 10.1111/aji.13791 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2023. Verfasst von Wenzhi Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology, Shaanxi Provincial People's Hospital, Xi'an, China. Hauptthemen laut MEDLINE: MicroRNAs, Choriocarcinoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emerging role of microRNA‐935 (miR‐935) in modulating cancer progression has been recognized. However, its role in regulating choriocarcinoma (CCA) development and progression remains unknown. The present work aims to reveal the effect of miR‐935 on CCA cell tumor properties and the related mechanism. The RNA expression of methyltransferase 3, N6‐adenosine‐methyltransferase complex catalytic subunit (METTL3), miR‐935, and gap junction protein alpha 1 (GJA1) was detected by quantitative real‐time polymerase chain reaction. Protein expression of GJA1, Ki67, and METTL3 was measured by western blotting and immunohistochemistry assays. CCK‐8 and colony formation were used to analyze cell proliferation. Transwell assays were performed to assess cell migration and invasion. Angiogenesis was investigated by tube formation assay. Xenograft mouse model assay was used to determine miR‐935‐mediated effect on tumor formation in vivo. The luciferase reporter assay and RNA pull‐down assay were used to verify the relationship between miR‐935 and GJA1. MeRIP assay was used to analyze the m6A methylation of pri‐miR‐935. MiR‐935 expression was significantly upregulated in CCA tissues and cells when compared with control groups. MiR‐935 overexpression promoted CCA cell proliferation, migration, invasion, and tube formation and tumor tumorigenesis in vitro and in vivo, but miR‐935 knockdown showed the opposite effects. In addition, miR‐935 targeted GJA1 and mediated CCA cell tumor properties by negatively regulating GJA1 expression. METTL3 promoted miR‐935 maturation by inducing m6A methylation of pri‐miR‐935, and its overexpression contributed to CCA cell tumor properties through the regulation of miR‐935. METTL3 promoted choriocarcinoma progression by m6A‐dependently activating the miR‐935/GJA1 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsChoriocarcinomaFemalePregnancyHumansAnimalsMiceCell Line, TumorMethyltransferasesCell MovementConnexin 43

Stichwörter der Autor:innen

CCAGJA1METTL3miR-935

Substanzen

MicroRNAsMethyltransferasesMETTL3 protein, humanGJA1 protein, humanConnexin 43MIRN-935 microRNA, humanGJA1 protein, mouse

Autor:innen und Institutionen

  • Department of Gynaecology, Shaanxi Provincial People's Hospital, Xi'an, China.
  • College of Pharmacy, Xi'an Medical University, Xi'an, China.

ORCID-Profile: Wenzhi Wang

Zitieren

APA

Wang, W., Shi, J., & Zheng, L. (2023). METTL3 promotes choriocarcinoma progression by activating the miR‐935/GJA1 pathway in an m6A‐dependent manner. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.13791

Vancouver

Wang W, Shi J, Zheng L. METTL3 promotes choriocarcinoma progression by activating the miR‐935/GJA1 pathway in an m6A‐dependent manner. American Journal of Reproductive Immunology. 2023. doi:10.1111/aji.13791

BibTeX
@article{Wang2023,
  author = {Wang, Wenzhi and Shi, Jianyong and Zheng, Lei},
  title = {METTL3 promotes choriocarcinoma progression by activating the miR‐935/GJA1 pathway in an m6A‐dependent manner},
  journal = {American Journal of Reproductive Immunology},
  year = {2023},
  doi = {10.1111/aji.13791}
}
Kostenlos starten →